Monaco Asset Management SAM Has $3.98 Million Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Monaco Asset Management SAM lifted its position in Teladoc Health, Inc. (NYSE:TDOC) by 22.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 500,000 shares of the health services provider’s stock after buying an additional 90,000 shares during the quarter. Teladoc Health comprises approximately 0.8% of Monaco Asset Management SAM’s holdings, making the stock its 13th largest position. Monaco Asset Management SAM owned 0.29% of Teladoc Health worth $3,980,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of TDOC. Golden State Wealth Management LLC increased its position in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock worth $27,000 after buying an additional 1,690 shares during the period. Sterling Capital Management LLC boosted its position in shares of Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock valued at $42,000 after acquiring an additional 4,101 shares during the period. Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Teladoc Health in the fourth quarter valued at approximately $60,000. Westside Investment Management Inc. grew its stake in shares of Teladoc Health by 16.8% in the first quarter. Westside Investment Management Inc. now owns 10,750 shares of the health services provider’s stock worth $86,000 after acquiring an additional 1,550 shares during the last quarter. Finally, Brucke Financial Inc. bought a new position in Teladoc Health during the fourth quarter worth $92,000. 76.82% of the stock is owned by institutional investors.

Insider Transactions at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 3,958 shares of Teladoc Health stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the transaction, the insider owned 17,645 shares in the company, valued at approximately $121,044.70. The trade was a 18.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Adam C. Vandervoort sold 5,808 shares of the stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $39,842.88. Following the sale, the insider owned 69,773 shares in the company, valued at $478,642.78. The trade was a 7.68% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 18,656 shares of company stock valued at $128,189. Corporate insiders own 0.58% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on TDOC shares. Citigroup reduced their price target on shares of Teladoc Health from $11.00 to $8.75 and set a “neutral” rating for the company in a report on Friday, April 25th. Stifel Nicolaus cut their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, May 1st. Wells Fargo & Company decreased their target price on Teladoc Health from $10.00 to $8.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 8th. Bank of America lowered their price target on Teladoc Health from $8.00 to $7.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 28th. Finally, Evercore ISI raised their price objective on Teladoc Health from $7.00 to $8.00 and gave the stock an “in-line” rating in a research report on Wednesday, July 9th. Thirteen research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $9.67.

Teladoc Health Stock Down 8.1%

Shares of NYSE TDOC opened at $7.54 on Wednesday. Teladoc Health, Inc. has a 52-week low of $6.35 and a 52-week high of $15.21. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.64 and a current ratio of 1.68. The business has a fifty day moving average of $7.69 and a two-hundred day moving average of $8.55. The stock has a market cap of $1.32 billion, a PE ratio of -1.27 and a beta of 1.84.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative net margin of 39.66% and a negative return on equity of 11.01%. The business had revenue of $631.90 million during the quarter, compared to analysts’ expectations of $621.91 million. During the same quarter last year, the company posted ($0.38) EPS. The firm’s revenue for the quarter was down 1.6% on a year-over-year basis. As a group, equities research analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.